The phrase "a robust reduction of" is correct and usable in written English.
It can be used in contexts where you want to describe a significant or effective decrease in something, such as costs, risks, or emissions.
Example: "The new policy aims for a robust reduction of carbon emissions over the next decade."
Alternatives: "a significant decrease in" or "a substantial cut in".
told reporters that he expects a "robust reduction" of U.S. troops from Afghanistan in July.
Syntaxin deletion resulted in secretion defects and a robust reduction of docking in neurosecretory cells, but not in CNS synapses.
Statistic analysis of tumor size shows a robust reduction of 68% at day 16 and 51% at day 20, confirming the potent anti-leukemic effect of acadesine in vivo.
It is also possible that events typical of enhanced protein translation initiation occur in the myocardium during early endotoxaemia, but this remains speculative with the lack of a robust reduction of AKT phosphorylation in fast-twitch muscle.
The validation of this test was demonstrated by the stronger drive to chew a chocolate cookie than to chew a regular food pellet as a robust reduction of the chewing latency with the chocolate cookie when compared with the regular food.
This translated into a robust reduction of the SR-Ca2+-leak.
One important observation we made is that while administration of ritonavir to ApoE−/− mice increased the percentage of CD36 positive monocytes, chronic administration of CDCA caused a robust reduction in the percentage of CD14/CD36 positive cells in ApoE−/− mice treated with ritonavir.
Simultaneous western Blot analysis demonstrated a robust reduction in the expression of ASS protein levels in cells treated with ASS-specific siRNA.
There were no differences in baseline characteristics except that patients with a robust reduction in SBP, irrespective of the UAE response, had a higher average baseline SBP and diastolic BP compared with patients without robust SBP decline.
Furthermore, patients who switched from placebo to the active drug experienced a robust reduction in the number of contrast-enhancing lesions (within-group comparison at month 6 versus month 12).
A more robust reduction of activity (70%) was observed when the –673pGL3 construct was introduced.
